ID   PAWR_RAT                Reviewed;         332 AA.
AC   Q62627;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 133.
DE   RecName: Full=PRKC apoptosis WT1 regulator protein;
DE   AltName: Full=Prostate apoptosis response 4 protein;
DE            Short=Par-4;
DE   AltName: Full=Transcriptional repressor Par-4-like protein PAWR;
GN   Name=Pawr; Synonyms=Par4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Prostate;
RX   PubMed=8043520;
RA   Sells S.F., Wood D.P. Jr., Joshi-Barve S.S., Muthukumar S., Jacob R.J.,
RA   Crist S.A., Humphreys S., Rangnekar V.M.;
RT   "Commonality of the gene programs induced by effectors of apoptosis in
RT   androgen-dependent and -independent prostate cells.";
RL   Cell Growth Differ. 5:457-466(1994).
RN   [2]
RP   DOMAIN SAC, MUTAGENESIS, AND SUBCELLULAR LOCATION.
RX   PubMed=12897127; DOI=10.1128/mcb.23.16.5516-5525.2003;
RA   El-Guendy N., Zhao Y., Gurumurthy S., Burikhanov R., Rangnekar V.M.;
RT   "Identification of a unique core domain of par-4 sufficient for selective
RT   apoptosis induction in cancer cells.";
RL   Mol. Cell. Biol. 23:5516-5525(2003).
RN   [3]
RP   PHOSPHORYLATION AT THR-155 BY PKA.
RX   PubMed=15657440; DOI=10.1128/mcb.25.3.1146-1161.2005;
RA   Gurumurthy S., Goswami A., Vasudevan K.M., Rangnekar V.M.;
RT   "Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.";
RL   Mol. Cell. Biol. 25:1146-1161(2005).
RN   [4]
RP   INTERACTION WITH ACTIN.
RX   PubMed=15817164; DOI=10.1016/j.yexcr.2005.01.012;
RA   Vetterkind S., Illenberger S., Kubicek J., Boosen M., Appel S., Naim H.Y.,
RA   Scheidtmann K.H., Preuss U.;
RT   "Binding of Par-4 to the actin cytoskeleton is essential for Par-4/Dlk-
RT   mediated apoptosis.";
RL   Exp. Cell Res. 305:392-408(2005).
CC   -!- FUNCTION: Pro-apoptotic protein capable of selectively inducing
CC       apoptosis in cancer cells, sensitizing the cells to diverse apoptotic
CC       stimuli and causing regression of tumors in animal models. Induces
CC       apoptosis in certain cancer cells by activation of the Fas prodeath
CC       pathway and coparallel inhibition of NF-kappa-B transcriptional
CC       activity. Inhibits the transcriptional activation and augments the
CC       transcriptional repression mediated by WT1. Down-regulates the anti-
CC       apoptotic protein BCL2 via its interaction with WT1. Seems also to be a
CC       transcriptional repressor by itself. May be directly involved in
CC       regulating the amyloid precursor protein (APP) cleavage activity of
CC       BACE1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homooligomer. Interacts (via the C-terminal region) with WT1.
CC       Interacts with THAP1. Interacts with AATF. Interacts with BACE1.
CC       Interacts with SPSB1 (via B30.2/SPRY domain); this interaction is
CC       direct and occurs in association with the Elongin BC complex. Interacts
CC       with SPSB2 (via B30.2/SPRY domain); this interaction occurs in
CC       association with the Elongin BC complex. Interacts with SPSB4 (via
CC       B30.2/SPRY domain); this interaction occurs in association with the
CC       Elongin BC complex. Component of a ternary complex composed of SQSTM1
CC       and PRKCZ (By similarity). Interacts with actin (PubMed:15817164).
CC       {ECO:0000250|UniProtKB:Q925B0, ECO:0000250|UniProtKB:Q96IZ0,
CC       ECO:0000269|PubMed:15817164}.
CC   -!- INTERACTION:
CC       Q62627; O88764: Dapk3; NbExp=5; IntAct=EBI-1187240, EBI-4404236;
CC       Q62627; Q9JMG6: Tfpt; NbExp=8; IntAct=EBI-1187240, EBI-1767101;
CC       Q62627; P11021: HSPA5; Xeno; NbExp=4; IntAct=EBI-1187240, EBI-354921;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Mainly cytoplasmic in absence of apoptosis signal and in normal
CC       cells. Nuclear in most cancer cell lines. Nuclear entry seems to be
CC       essential but not sufficient for apoptosis. Nuclear localization
CC       includes nucleoplasm and PML nuclear bodies (By similarity).
CC       {ECO:0000250}.
CC   -!- INDUCTION: In ventral prostate following castration.
CC       {ECO:0000269|PubMed:8043520}.
CC   -!- DOMAIN: The leucine-zipper domain is not essential for apoptosis, but
CC       is required for sensitization of cells to exogenous apoptotic insults
CC       and for interaction with its partners. {ECO:0000250}.
CC   -!- DOMAIN: The SAC domain is a death-inducing domain selective for
CC       apoptosis induction in cancer cells. This domain is essential for
CC       nuclear entry, Fas activation, inhibition of NF-kappa-B activity and
CC       induction of apoptosis in cancer cells (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The B30.2/SPRY domain-binding motif mediates recognition by
CC       proteins containing a B30.2/SPRY domain.
CC       {ECO:0000250|UniProtKB:Q96IZ0}.
CC   -!- PTM: Preferentially phosphorylated at the Thr-155 by PKC in cancer
CC       cells. {ECO:0000269|PubMed:15657440}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U05989; AAA16492.1; -; mRNA.
DR   RefSeq; NP_277020.1; NM_033485.2.
DR   PDB; 5FIY; X-ray; 3.00 A; A/B/C/D/E/F/G=240-332.
DR   PDBsum; 5FIY; -.
DR   AlphaFoldDB; Q62627; -.
DR   SMR; Q62627; -.
DR   BioGRID; 249098; 4.
DR   IntAct; Q62627; 5.
DR   STRING; 10116.ENSRNOP00000008222; -.
DR   iPTMnet; Q62627; -.
DR   PhosphoSitePlus; Q62627; -.
DR   PaxDb; 10116-ENSRNOP00000008222; -.
DR   DNASU; 64513; -.
DR   GeneID; 64513; -.
DR   KEGG; rno:64513; -.
DR   UCSC; RGD:69065; rat.
DR   AGR; RGD:69065; -.
DR   CTD; 5074; -.
DR   RGD; 69065; Pawr.
DR   eggNOG; ENOG502QVUF; Eukaryota.
DR   InParanoid; Q62627; -.
DR   OrthoDB; 5362291at2759; -.
DR   PhylomeDB; Q62627; -.
DR   PRO; PR:Q62627; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:RGD.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IPI:RGD.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEP:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IDA:RGD.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IDA:RGD.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0090281; P:negative regulation of calcium ion import; IDA:RGD.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045760; P:positive regulation of action potential; IDA:RGD.
DR   GO; GO:0042986; P:positive regulation of amyloid precursor protein biosynthetic process; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2000774; P:positive regulation of cellular senescence; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0060450; P:positive regulation of hindgut contraction; IDA:RGD.
DR   GO; GO:1901300; P:positive regulation of hydrogen peroxide-mediated programmed cell death; ISO:RGD.
DR   GO; GO:1903238; P:positive regulation of leukocyte tethering or rolling; IDA:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:1904457; P:positive regulation of neuronal action potential; IMP:RGD.
DR   GO; GO:2000391; P:positive regulation of neutrophil extravasation; IDA:RGD.
DR   GO; GO:1901082; P:positive regulation of relaxation of smooth muscle; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0010040; P:response to iron(II) ion; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   DisProt; DP00940; -.
DR   InterPro; IPR026117; Par-4.
DR   PANTHER; PTHR15093:SF1; PRKC APOPTOSIS WT1 REGULATOR PROTEIN; 1.
DR   PANTHER; PTHR15093; PROSTATE APOPTOSIS RESPONSE PROTEIN PAR-4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Coiled coil; Cytoplasm; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..332
FT                   /note="PRKC apoptosis WT1 regulator protein"
FT                   /id="PRO_0000058238"
FT   REGION          1..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          137..195
FT                   /note="Selective for apoptosis induction in cancer cells
FT                   (SAC)"
FT   REGION          292..332
FT                   /note="Leucine-zipper"
FT   COILED          176..198
FT                   /evidence="ECO:0000255"
FT   MOTIF           61..65
FT                   /note="B30.2/SPRY domain-binding motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q96IZ0"
FT   MOTIF           137..153
FT                   /note="Nuclear localization signal"
FT   COMPBIAS        1..15
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..154
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        186..218
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        230..244
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         155
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:15657440"
FT   MOD_RES         223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96IZ0"
FT   HELIX           257..330
FT                   /evidence="ECO:0007829|PDB:5FIY"
SQ   SEQUENCE   332 AA;  35866 MW;  2069B32DEFFF160F CRC64;
     MATGGYRSSG STTDFLEEWK AKREKMRAKQ NPVGPGSSGG DPAAKSPAGP LAQTTAAGTS
     ELNHGPAGAA APAAPGPGAL NCAHGSSALP RGAPGSRRPE DECPIAAGAA GAPASRGDEE
     EPDSAPEKGR SSGPSARKGK GQIEKRKLRE KRRSTGVVNI PAAECLDEYE DDEAGQKERK
     REDAITQQNT IQNEAASLPD PGTSYLPQDP SRTVPGRYKS TISAPEEEIL NRYPRTDRSG
     FSRHNRDTSA PANFASSSTL EKRIEDLEKE VLRERQENLR LTRLMQDKEE MIGKLKEEID
     LLNRDLDDME DENEQLKQEN KTLLKVVGQL TR
//
